Ftse Mib
33.738,78
-0,08%
DAX
19.848,77
-0,34%
S&P 500
5.974,07
0,73%
NASDAQ
19.764,89
0,98%
Bitcoin
94.486,25
-0,66%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Canada TSXV Cotec Holdings Corp (CTH) Cotec Holdings Corp (CTH) Notizie

CTH

Cotec (CTH)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSXV:CTH
DataOraFonteTitoloSimboloCompagnia
19/11/201415:35PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - CTHTSXV:CTHCotec Holdings Corp
19/11/201415:33PR Newswire (Canada)IIROC Trading Resumption - CTHTSXV:CTHCotec Holdings Corp
18/11/201422:12PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - CTHTSXV:CTHCotec Holdings Corp
18/11/201422:10PR Newswire (Canada)IIROC Trading Halt - CTHTSXV:CTHCotec Holdings Corp
17/07/201422:15Marketwired CanadaCynapsus Therapeutics Commences Phase 2 Clinical Trials in the United StatesTSXV:CTHCotec Holdings Corp
08/07/201412:00Marketwired CanadaCynapsus Therapeutics Awarded Second Grant from The Michael J. Fox Foundation for Parkinson's ResearchTSXV:CTHCotec Holdings Corp
20/05/201422:42MarketwiredCynapsus Therapeutics Grants Stock OptionsTSXV:CTHCotec Holdings Corp
14/05/201412:00MarketwiredCynapsus Announces No Buccal Mucosal Irritation in FDA Registration Study of APL-130277 for Parkinson's DiseaseTSXV:CTHCotec Holdings Corp
07/05/201423:30Marketwired CanadaCynapsus Therapeutics Reports First Quarter 2014 Financial Results and Recent DevelopmentsTSXV:CTHCotec Holdings Corp
24/04/201412:00MarketwiredCynapsus Announces Positive Results of CTH-104 Clinical Study of APL-130277 for Parkinson's DiseaseTSXV:CTHCotec Holdings Corp
15/04/201416:27Marketwired CanadaCynapsus Therapeutics Completes $25,000,000 Short Form Prospectus OfferingTSXV:CTHCotec Holdings Corp
09/04/201404:14Marketwired CanadaCynapsus Therapeutics Files Final Short Form ProspectusTSXV:CTHCotec Holdings Corp
28/03/201421:50Marketwired CanadaCynapsus Therapeutics Files Preliminary Short Form ProspectusTSXV:CTHCotec Holdings Corp
28/03/201411:00MarketwiredCynapsus Announces Interim Summary Results of Human Healthy Volunteer Single 25mg Study for APL-130277TSXV:CTHCotec Holdings Corp
27/03/201421:00MarketwiredCynapsus Therapeutics Reports 2013 Financial Results and Highlights Key DevelopmentsTSXV:CTHCotec Holdings Corp
27/02/201415:22MarketwiredCynapsus Therapeutics Announces DTC ApprovalTSXV:CTHCotec Holdings Corp
13/02/201414:00MarketwiredCynapsus Therapeutics Appoints Nan Hutchinson to the Board of DirectorsTSXV:CTHCotec Holdings Corp
07/02/201415:15MarketwiredLifeSci Advisors Initiates Coverage of Cynapsus Therapeutics, Inc.TSXV:CTHCotec Holdings Corp
23/01/201422:00MarketwiredCynapsus Therapeutics Announces Exercise of WarrantsTSXV:CTHCotec Holdings Corp
22/01/201422:30MarketwiredCynapsus Announces Resignation of Chief Scientific OfficerTSXV:CTHCotec Holdings Corp
13/01/201412:00MarketwiredCynapsus Announces Completion of Human Healthy Volunteer Crossover Study Results for APL-130277TSXV:CTHCotec Holdings Corp
26/11/201314:00Marketwired CanadaSeeThruEquity, LLC Initiates Coverage on Cynapsus Therapeutics Inc.TSXV:CTHCotec Holdings Corp
21/11/201321:42Marketwired CanadaCynapsus Therapeutics Reports Third Quarter 2013 Financial Results and Recent DevelopmentsTSXV:CTHCotec Holdings Corp
10/10/201317:04Marketwired CanadaGoldquest, Micromem Technologies, Cynapsus Therapeutics and Excalibur Resources Featured on Episode 14 of the Next Biggest Wi...TSXV:CTHCotec Holdings Corp
22/08/201322:17Marketwired CanadaCynapsus Therapeutics Reports Second Quarter 2013 Financial Results and Recent DevelopmentsTSXV:CTHCotec Holdings Corp
18/07/201313:00Marketwired CanadaCynapsus Therapeutics Begins Trading on the OTCQX Marketplace in the United StatesTSXV:CTHCotec Holdings Corp
30/05/201315:00Marketwired CanadaCynapsus Therapeutics to Present at the SeeThruEquity Second Annual Investor Conference on June 4, 2013 at 10:00 AM EDTTSXV:CTHCotec Holdings Corp
23/05/201315:28Marketwired CanadaCynapsus Therapeutics Reports First Quarter 2013 Financial Results and Recent DevelopmentsTSXV:CTHCotec Holdings Corp
15/05/201312:00Marketwired CanadaCynapsus Therapeutics Publishes White Paper on Apomorphine for 'Off' Periods in Parkinson's Disease and Its Alternative Deliv...TSXV:CTHCotec Holdings Corp
09/05/201322:45Marketwired CanadaCynapsus Therapeutics Appoints Two New DirectorsTSXV:CTHCotec Holdings Corp
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSXV:CTH

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
ENI
Eni
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STMMI
ST Microelectronics
BIT
TIT
Telecom Italia
BIT
LDO
Leonardo
BIT
RACE
Ferrari NV
BIT
PRY
Prysmian
BIT
SPM
Saipem
BIT
BPE
Bper Banca
BIT
CPR
Davide Campari
BIT
AMP
Amplifon
BIT
SRG
Snam
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network